Holen Sie sich die Stockscreener-App
7.96
4.56%
-0.38
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NEO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$8.34
Offen:
$8.38
24-Stunden-Volumen:
1.86M
Relative Volume:
0.75
Marktkapitalisierung:
$1.03B
Einnahmen:
$628.25M
Nettoeinkommen (Verlust:
$-78.55M
KGV:
-12.84
EPS:
-0.62
Netto-Cashflow:
$-29.73M
1W Leistung:
-0.25%
1M Leistung:
+30.92%
6M Leistung:
-22.19%
1J Leistung:
-50.86%
1-Tages-Spanne:
$7.905
$8.38
1-Wochen-Bereich:
$7.36
$8.42
52-Wochen-Spanne:
$4.72
$19.11
Neogenomics Inc Stock (NEO) Company Profile
Firmenname
Neogenomics Inc
Sektor
Branche
Telefon
(239) 768-0600
Adresse
9490 NEOGENOMICS WAY, FORT MYERS, FL
Vergleichen Sie NEO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
7.96 | 966.26M | 628.25M | -78.55M | -29.73M | -0.62 |
|
TMO
Thermo Fisher Scientific Inc
|
479.46 | 179.95B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
190.05 | 137.90B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
641.14 | 51.04B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
123.24 | 35.19B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
187.22 | 31.26B | 15.70B | 1.24B | 2.01B | 6.91 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-30 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-07-29 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-05-15 | Eingeleitet | Guggenheim | Neutral |
| 2025-04-30 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-12-10 | Eingeleitet | Jefferies | Buy |
| 2024-05-01 | Fortgesetzt | Craig Hallum | Buy |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-08-21 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-02-24 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-02-01 | Hochstufung | Needham | Hold → Buy |
| 2022-08-26 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-22 | Herabstufung | Needham | Buy → Hold |
| 2022-06-03 | Eingeleitet | Piper Sandler | Overweight |
| 2022-03-29 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-03-29 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | Fortgesetzt | Stephens | Overweight |
| 2021-12-16 | Eingeleitet | Cowen | Outperform |
| 2021-11-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-02-25 | Fortgesetzt | Needham | Buy |
| 2021-02-25 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-12-11 | Fortgesetzt | BTIG Research | Buy |
| 2020-10-28 | Bestätigt | Needham | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-28 | Eingeleitet | Guggenheim | Buy |
| 2020-07-29 | Bestätigt | Needham | Buy |
| 2020-06-25 | Eingeleitet | BofA/Merrill | Buy |
| 2020-04-21 | Fortgesetzt | Stephens | Overweight |
| 2020-03-02 | Fortgesetzt | Craig Hallum | Buy |
| 2020-02-28 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-05-01 | Bestätigt | Needham | Buy |
| 2019-03-29 | Bestätigt | Needham | Buy |
| 2019-01-03 | Eingeleitet | Needham | Buy |
| 2018-10-24 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | Eingeleitet | Leerink Partners | Outperform |
| 2018-05-02 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2017-08-24 | Eingeleitet | Gabelli & Co | Buy |
| 2016-12-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Neogenomics Inc Aktie (NEO) Neueste Nachrichten
Intraday pattern recognizer results for NeoGenomics Inc.July 2025 Spike Watch & Growth Focused Stock Reports - Newser
Technical signs of recovery in NeoGenomics Inc.Earnings Growth Summary & Reliable Price Breakout Signals - Newser
Applying sector rotation models to NeoGenomics Inc.Trade Entry Summary & Community Verified Watchlist Alerts - Newser
Has NeoGenomics Inc. found a price floorWeekly Profit Analysis & Weekly Chart Analysis and Trade Guides - Newser
Fred Alger Management LLC Sells 138,182 Shares of NeoGenomics, Inc. $NEO - MarketBeat
Why NeoGenomics (NEO) Shares Are Falling Today - Yahoo Finance
Why Natera (NTRA) Shares Are Falling Today - FinancialContent
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc.NEO - FinancialContent
What are NeoGenomics Inc.’s recent SEC filings showing2025 Volume Leaders & Safe Capital Growth Tips - Lancaster City Council
Northern Trust Corp Cuts Stock Position in NeoGenomics, Inc. $NEO - MarketBeat
Price Floor Holding on NeoGenomics Inc. — Rebound PossibleJuly 2025 PostEarnings & Low Volatility Stock Recommendations - beatles.ru
What are the future prospects of NeoGenomics Inc.Swing Trade & Scalable Portfolio Growth Methods - beatles.ru
NeoGenomics (NASDAQ:NEO) Shares Down 5.2%Should You Sell? - MarketBeat
Should value investors consider NeoGenomics Inc.2025 Key Lessons & Fast Moving Stock Trade Plans - beatles.ru
Tech Rally: Why is NeoGenomics Inc. stock going upEarnings Overview Summary & Verified Momentum Stock Watchlist - classian.co.kr
NeoGenomics (NASDAQ:NEO) Given New $11.00 Price Target at Stephens - MarketBeat
First Light Asset Management LLC Has $57.35 Million Stock Position in NeoGenomics, Inc. $NEO - MarketBeat
Will NeoGenomics Inc. benefit from geopolitical trendsJuly 2025 Decliners & High Accuracy Investment Entry Signals - خودرو بانک
Hsbc Holdings PLC Lowers Position in NeoGenomics, Inc. $NEO - Defense World
What data driven models say about NeoGenomics Inc.’s future2025 Institutional Moves & Reliable Breakout Forecasts - Newser
Ranking NeoGenomics Inc. among high performing stocks via toolsGold Moves & Breakout Confirmation Trade Signals - Newser
Is now a turning point for NeoGenomics Inc.Market Volume Report & Long Hold Capital Preservation Tips - Newser
Why is NeoGenomics Inc. stock going upPortfolio Gains Summary & Free Accurate Trade Setup Notifications - خودرو بانک
What chart patterns are forming on NeoGenomics Inc.Weekly Profit Summary & Safe Capital Growth Plans - خودرو بانک
Is NeoGenomics Inc. stock a value trapJuly 2025 Highlights & AI Powered Buy/Sell Recommendations - خودرو بانک
NeoGenomics, Inc. $NEO Stock Holdings Lifted by Gabelli Funds LLC - MarketBeat
Published on: 2025-09-04 23:30:35 - Newser
Signal strength of NeoGenomics Inc. stock in tech scannersJuly 2025 Selloffs & Risk Controlled Daily Plans - Newser
Brown Advisory Small-Cap Growth Strategy Sold Neogenomics (NEO) Following the News of CEO Departure - Insider Monkey
What is NeoGenomics Inc. s revenue forecastJuly 2025 Levels & Daily Chart Pattern Signal Reports - خودرو بانک
How to manage a losing position in NeoGenomics Inc.Portfolio Growth Summary & Consistent Return Investment Signals - Newser
Using Python tools to backtest NeoGenomics Inc. strategiesGap Up & Verified Entry Point Signals - Newser
Natera (NTRA) Provides an Update on its Intellectual Property Litigation With NeoGenomics - MSN
How moving averages guide NeoGenomics Inc. tradingJuly 2025 Breakouts & Verified Chart Pattern Signals - Newser
Fed Meeting: How does NeoGenomics Inc. perform in inflationary periodsMarket Performance Recap & Long Hold Capital Preservation Plans - خودرو بانک
NeoGenomics (NASDAQ:NEO) Is Making Moderate Use Of Debt - 富途牛牛
Liquid Biopsy in Cancer Diagnostics Market to Witness Robust ~17% CAGR Expansion by 2032 | DelveInsight - Barchart.com
Applying big data sentiment scoring on NeoGenomics Inc.Analyst Downgrade & Risk Managed Investment Signals - Newser
Real time social sentiment graph for NeoGenomics Inc.Weekly Profit Report & High Return Trade Guides - Newser
Should I trade or invest in NeoGenomics Inc.Market Trend Summary & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
What’s next for NeoGenomics Inc. stock priceGDP Growth & Pattern Based Trade Signal System - Newser
When is the best time to exit NeoGenomics Inc.July 2025 Market Mood & Fast Exit and Entry Strategy Plans - Newser
Is NeoGenomics Inc. meeting your algorithmic filter criteriaJuly 2025 Review & Technical Pattern Recognition Alerts - Newser
Can momentum traders help lift NeoGenomics Inc.Earnings Recap Summary & Fast Entry Momentum Trade Alerts - Newser
Does NeoGenomics Inc. qualify in momentum factor screeningPrice Action & Precise Trade Entry Recommendations - Newser
Chart based analysis of NeoGenomics Inc. trendsTrend Reversal & AI Forecast Swing Trade Picks - Newser
Does NeoGenomics Inc. have a sustainable dividendTrade Analysis Report & Risk Managed Investment Strategies - خودرو بانک
Finanzdaten der Neogenomics Inc-Aktie (NEO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):